List of publications

Balcar L; Scheiner B; Urheu M; Weinberger P; Paternostro R; Simbrunner B; Hartl L; Jachs M; Bauer D; Semmler G; Willheim C; Pinter M; Ferenci P; Trauner M; Reiberger T; Stättermayer AF; Mandorfer M, 2022. Alpha-1 antitrypsin Pi∗Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver disease.  JHEP Rep 4(11):100562

Burghart L; Halilbasic E; Schwabl P; Simbrunner B; Stättermayer AF; Petrenko O; Scheiner B; Bauer D; Pinter M; Boztug K; Mandorfer M; Trauner M; Reiberger T, 2022. Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis.  J Gastroenterol 57(2):99-110

Brusilovskaya K; Simbrunner B; Lee S; Eichelberger B; Bauer D; Zinober K; Schwabl P; Mandorfer M; Panzer S; Reiberger T; Gremmel T, 2022. Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis.  Platelets 33(6):879-886

Chromy D; Bauer DJM; Simbrunner B; Jachs M; Hartl L; Schwabl P; Schwarz C; Rieger A; Grabmeier-Pfistershammer K; Trauner M; Ferenci P; Mandorfer M; Gschwantler M; Reiberger T, 2022. The 'Viennese epidemic' of acute HCV in the era of direct-acting antivirals.  J Viral Hepat 29(5):385-394

Schwabl P; Seeland BA; Riedl F; Schubert TL; Königshofer P; Brusilovskaya K; Petrenko O; Hofer B; Schiefer AI; Trauner M; Peck-Radosavljevic M; Reiberger T, 2022. Splenectomy ameliorates portal pressure and anemia in animal models of cirrhotic and non-cirrhotic portal hypertension.  Adv Med Sci 67(1):154-162

Bauer DJ; Matic V; Mare R; Maiocchi L; Chromy D; Müllner-Bucsics T; Mandorfer M; Mustapic S; Sporea I; Ferraioli G; Grgurevic I; Reiberger T, 2022. Point Shear Wave Elastography by ElastPQ for Fibrosis Screening in Patients with NAFLD: A Prospective, Multicenter Comparison to Vibration-Controlled Elastography.  Ultraschall Med.

Jachs M; Hartl L; Bauer D; Simbrunner B; Stättermayer AF; Strassl R; Trauner M; Mandorfer M; Reiberger T, 2022. Long-Term Outcome of HBV-Infected Patients with Clinically Significant Portal Hypertension Achieving Viral Suppression.  J Pers Med 12.

de Franchis R; Bosch J; Garcia-Tsao G; Reiberger T; Ripoll C, 2022. Baveno VII - Renewing consensus in portal hypertension.  J Hepatol 76(4):959-974

Reiterer C; Taschner A; Luf F; Hecking M; Tamandl D; Zotti O; Reiberger T; Starlinger P; Mandorfer M; Fleischmann E, 2022. Effect of liver resection-induced increases in hepatic venous pressure gradient on development of postoperative acute kidney injury.  BMC Nephrol 23(1):21

Innes H; Nischalke HD; Guha IN; Weiss KH; Irving W; Gotthardt D; Barnes E; Fischer J; Ansari MA; Rosendahl J; Lin SK; Marot A; Pedergnana V; Casper M; Benselin J; Lammert F; McLauchlan J; Lutz PL; Hamill V; Mueller S; Morling JR; Semmler G; Eyer F; von Felden J; Link A; Vogel A; Marquardt JU; Sulk S; Trebicka J; Valenti L; Datz C; Reiberger T; Schafmayer C; Berg T; Deltenre P; Hampe J; Stickel F; Buch S, 2022. The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis.  Hepatol Commun 6(5):1213-1226

Lampichler K; Semmler G; Wöran K; Simbrunner B; Jachs M; Hartl L; Bauer DJM; Balcar L; Burghart L; Trauner M; Tamandl D; Ba-Ssalamah A; Mandorfer M; Reiberger T; Scheiner B; Scharitzer M, 2022. Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder.  Eur Radiol.

Reiberger T, 2022. The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis.  Hepatol Commun 6(5):950-964

Semmler G; Meyer EL; Kozbial K; Schwabl P; Hametner-Schreil S; Zanetto A; Bauer D; Chromy D; Simbrunner B; Scheiner B; Stättermayer AF; Pinter M; Schöfl R; Russo FP; Greenfield H; Schwarz M; Schwarz C; Gschwantler M; Alonso López S; Manzano ML; Ahumada A; Bañares R; Pons M; Rodríguez-Tajes S; Genescà J; Lens S; Trauner M; Ferenci P; Reiberger T; Mandorfer M, 2022. HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease.  J Hepatol 76(4):812-821

Schwarz C; Chromy D; Bangert C; Schwarz M; Jachs M; Reiberger T; Gschwantler M, 2022. Immediate-type hypersensitivity reaction to bulevirtide and successful desensitization in a patient with HBV/HDV-associated compensated cirrhosis.  J Hepatol 77(1):254-255

Paternostro R; Becker J; Hofer BS; Panagl V; Schiffke H; Simbrunner B; Semmler G; Schwabl P; Scheiner B; Bucsics T; Bauer D; Binter T; Trauner M; Mandorfer M; Reiberger T, 2022. The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices.  Dig Liver Dis 54(4):500-508

Königshofer P; Hofer BS; Brusilovskaya K; Simbrunner B; Petrenko O; Wöran K; Herac M; Stift J; Lampichler K; Timelthaler G; Bauer D; Hartl L; Robl B; Sibila M; Podesser BK; Oberhuber G; Schwabl P; Mandorfer M; Trauner M; Reiberger T, 2022. Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies.  Hepatology 75(3):610-622

Bassegoda O; Olivas P; Turco L; Mandorfer M; Serra-Burriel M; Tellez L; Kwanten W; Laroyenne A; Farcau O; Alvarado E; Moga L; Vuille-Lessard E; Fortea JI; Ibañez L; Tosetti G; Vanwolleghem T; Larrue H; Burgos-Santamaría D; Stefanescu H; Paternostro R; Cippitelli A; Lens S; Augustin S; Llop E; Laleman W; Trebicka J; Chang J; Masnou H; Zipprich A; Miceli F; Semmler G; Forns X; Primignani M; Bañares R; Puente A; Berzigotti A; Rautou PE; Villanueva C; Ginès P; Garcia-Pagan JC; Procopet B; Bureau C; Albillos A; Francque S; Reiberger T; Schepis F; Graupera I; Hernandez-Gea V, 2022. Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease.  Clin Gastroenterol Hepatol 20(10):2276-2286.e6

Scheiner B; Pomej K; Kirstein MM; Hucke F; Finkelmeier F; Waidmann O; Himmelsbach V; Schulze K; von Felden J; Fründt TW; Stadler M; Heinzl H; Shmanko K; Spahn S; Radu P; Siebenhüner AR; Mertens JC; Rahbari NN; Kütting F; Waldschmidt DT; Ebert MP; Teufel A; De Dosso S; Pinato DJ; Pressiani T; Meischl T; Balcar L; Müller C; Mandorfer M; Reiberger T; Trauner M; Personeni N; Rimassa L; Bitzer M; Trojan J; Weinmann A; Wege H; Dufour JF; Peck-Radosavljevic M; Vogel A; Pinter M, 2022. Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score.  J Hepatol 76(2):353-363

Stockhoff L; Muellner-Bucsics T; Markova AA; Schultalbers M; Keimburg SA; Tergast TL; Hinrichs JB; Simon N; Gerbel S; Manns MP; Mandorfer M; Cornberg M; Meyer BC; Wedemeyer H; Reiberger T; Maasoumy B, 2022. Low Serum Cholinesterase Identifies Patients With Worse Outcome and Increased Mortality After TIPS.  Hepatol Commun 6(3):621-632

Mandorfer M; Reiberger T; Jachs M, 2022. Reply.  Clin Gastroenterol Hepatol 20(6):e1514-e1515

Jachs M; Reiberger T; Mandorfer M, 2022. Reply.  Clin Gastroenterol Hepatol 20(6):e1512-e1513

Jachs M; Hartl L; Simbrunner B; Bauer D; Paternostro R; Scheiner B; Schwabl P; Stättermayer AF; Pinter M; Eigenbauer E; Quehenberger P; Trauner M; Reiberger T; Mandorfer M, 2022. Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and Death.  Clin Gastroenterol Hepatol 20(6):1362-1373.e6

Wöran K; Semmler G; Jachs M; Simbrunner B; Bauer DJM; Binter T; Pomej K; Stättermayer AF; Schwabl P; Bucsics T; Paternostro R; Lampichler K; Pinter M; Trauner M; Mandorfer M; Stift J; Reiberger T; Scheiner B, 2022. Clinical Course of Porto-Sinusoidal Vascular Disease Is Distinct From Idiopathic Noncirrhotic Portal Hypertension.  Clin Gastroenterol Hepatol 20(2):e251-e266

Trebicka J; Gu W; de Ledinghen V; Aubé C; Krag A; Praktiknjo M; Castera L; Dumortier J; Bauer DJM; Friedrich-Rust M; Pol S; Grgurevic I; Zheng R; Francque S; Gottfriedovà H; Mustapic S; Sporea I; Berzigotti A; Uschner FE; Simbrunner B; Ronot M; Cassinotto C; Kjaergaard M; Andrade F; Schulz M; Semmler G; Drinkovic IT; Chang J; Brol MJ; Rautou PE; Vanwolleghem T; Strassburg CP; Boursier J; Ferstl PG; Rasmussen DN; Reiberger T; Vilgrain V; Guibal A; Guillaud O; Zeuzem S; Vassord C; Lu X; Vonghia L; Senkerikova R; Popescu A; Margini C; Wang W; Thiele M; Jansen C, 2022. Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease.  Gut 71(2):402-414

Thaler J; Lisman T; Quehenberger P; Hell L; Schwabl P; Scheiner B; Bucsics T; Nieuwland R; Ay C; Trauner M; Pabinger I; Reiberger T; Mandorfer M, 2022. Intraperitoneal Activation of Coagulation and Fibrinolysis in Patients with Cirrhosis and Ascites.  Thromb Haemost 122(3):353-362

Bucsics T; Lampichler K; Vierziger C; Schoder M; Wolf F; Bauer D; Simbrunner B; Hartl L; Jachs M; Scheiner B; Trauner M; Gruenberger T; Karnel F; Mandorfer M; Reiberger T, 2022. Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis.  Dig Dis Sci.

Scheiner B; Balcar L; Nussbaumer RJ; Weinzierl J; Paternostro R; Simbrunner B; Hartl L; Jachs M; Bauer D; Stättermayer AF; Semmler G; Pinter M; Ay C; Quehenberger P; Trauner M; Reiberger T; Lisman T; Mandorfer M, 2022. Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD.  J Hepatol 76(5):1090-1099

Bauer D; Kozbial K; Schwabl P; Chromy D; Simbrunner B; Stättermayer AF; Pinter M; Steindl-Munda P; Trauner M; Ferenci P; Reiberger T; Mandorfer M, 2022. Angiopoietin 2 levels decrease after HCV-cure and reflect the evolution of portal hypertension.  Dig Liver Dis 54(9):1222-1229

Semmler G; Reiberger T; Scheiner B, 2022. Reply.  Clin Gastroenterol Hepatol.

Reiniš J; Petrenko O; Simbrunner B; Hofer BS; Schepis F; Scoppettuolo M; Saltini D; Indulti F; Guasconi T; Albillos A; Téllez L; Villanueva C; Brujats A; Garcia-Pagan JC; Perez-Campuzano V; Hernández-Gea V; Rautou PE; Moga L; Vanwolleghem T; Kwanten WJ; Francque S; Trebicka J; Gu W; Ferstl PG; Gluud LL; Bendtsen F; Møller S; Kubicek S; Mandorfer M; Reiberger T, 2022. Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis.  J Hepatol.

Zanetto A; Pelizzaro F; Campello E; Bulato C; Balcar L; Gu W; Gavasso S; Saggiorato G; Zeuzem S; Russo FP; Mandorfer M; Reiberger T; Trebicka J; Burra P; Simioni P; Senzolo M, 2022. Severity of systemic inflammation is the main predictor of ACLF and bleeding in patients with acutely decompensated cirrhosis.  J Hepatol.

Mrak D; Sieghart D; Simader E; Tobudic S; Radner H; Mandl P; Göschl L; Koblischke M; Hommer N; Wagner A; Mayer M; Schubert L; Hartl L; Kozbial K; Hofer P; Kartnig F; Hummel T; Kerschbaumer A; Deimel T; Puchner A; Gudipati V; Thalhammer R; Munda P; Uyanik-Ünal K; Zuckermann A; Novacek G; Reiberger T; Garner-Spitzer E; Reindl-Schwaighofer R; Kain R; Winkler S; Smolen JS; Stiasny K; Fischer GF; Perkmann T; Haslacher H; Zeitlinger M; Wiedermann U; Aberle JH; Aletaha D; Heinz LX; Bonelli M, 2022. Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial.  Nat Commun 13(1):5362

Paternostro R; Kwanten WJ; Reiberger T, 2022. Portal hypertension is a key determinant of the risk for liver-related events in non-alcoholic fatty liver disease.  J Hepatol.

Semmler G; Lens S; Meyer EL; Baiges A; Alvarado-Tapias E; Llop E; Tellez L; Schwabl P; Mauro E; Escudé L; Díez C; Ibañez-Samaniego L; Puente Á; Ignacio Fortea J; Abadía M; Zanetto A; Conthe A; Hernandez-Évole H; Sofia Luzko Scheid I; Jia J; Yoshiji H; Francque SM; Tsochatzis EA; Paolo Russo F; Crespo G; Forns X; Bañares R; Villanueva C; Hernández-Gea V; Reiberger T; Bosch J; García-Pagán JC; Mandorfer M, 2022. Non-invasive tests for clinically significant portal hypertension after HCV cure.  J Hepatol.

Hartl L; Jachs M; Bauer D; Simbrunner B; Chromy D; Binter T; Steininger L; Schwarz C; Schwarz M; Burghart L; Strassl R; Trauner M; Gschwantler M; Mandorfer M; Reiberger T, 2022. HCV hotline facilitates Hepatitis C elimination during the COVID-19 pandemic.  J Viral Hepat.

Hartl L; Haslinger K; Angerer M; Jachs M; Simbrunner B; Bauer DJM; Semmler G; Scheiner B; Eigenbauer E; Strassl R; Breuer M; Kimberger O; Laxar D; Trauner M; Mandorfer M; Reiberger T, 2022. Age-adjusted mortality and predictive value of liver chemistries in a Viennese cohort of COVID-19 patients.  Liver Int 42(6):1297-1307

Hassan R; Friebel A; Brackhagen L; Hobloss Z; Myllys M; González D; Albrecht W; Mohammed ESI; Seddek AL; Marchan R; Cadenas C; Cramer B; Humpf HU; Hartl L; Simbrunner B; Reiberger T; Trauner M; Hoehme S; Degen GH; Hengstler JG; Ghallab A, 2022. Hypoalbuminemia affects the spatio-temporal tissue distribution of ochratoxin A in liver and kidneys: consequences for organ toxicity.  Arch Toxicol 96(11):2967-2981

Jachs M; Reiberger T; Ferenci P, 2022. Editorial: pegylated interferon combined with bulevirtide for chronic hepatitis delta-new life for an old timer? Authors' reply.  Aliment Pharmacol Ther 56(5):914-915

Pomej K; Scheiner B; Balcar L; Nussbaumer RJ; Weinzierl J; Paternostro R; Simbrunner B; Bauer D; Pereyra D; Starlinger P; Stättermayer AF; Pinter M; Trauner M; Quehenberger P; Reiberger T; Mandorfer M, 2022. Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease.  Dig Liver Dis 54(10):1376-1384

Balcar L; Tonon M; Semmler G; Calvino V; Hartl L; Incicco S; Jachs M; Bauer D; Hofer BS; Gambino CG; Accetta A; Brocca A; Trauner M; Mandorfer M; Piano S; Reiberger T, 2022. Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event.  JHEP Rep 4(8):100513

Monin MB; Ingiliz P; Lutz T; Scholten S; Cordes C; Martínez-Rebollar M; Spinner CD; Nelson M; Rausch M; Bhagani S; Peters L; Reiberger T; Mauss S; Rockstroh JK; Boesecke C, 2022. Low spontaneous clearance rates of recently acquired hepatitis C virus in HIV-positive MSM (The PROBE-C Study).  Clin Infect Dis.

Jachs M; Hartl L; Simbrunner B; Bauer D; Paternostro R; Balcar L; Hofer B; Pfisterer N; Schwarz M; Scheiner B; Stättermayer AF; Pinter M; Trauner M; Mandorfer M; Reiberger T, 2022. Carvedilol Achieves Higher Hemodynamic Response and Lower Rebleeding Rates Than Propranolol in Secondary Prophylaxis.  Clin Gastroenterol Hepatol.

Buch S; Innes H; Lutz PL; Nischalke HD; Marquardt JU; Fischer J; Weiss KH; Rosendahl J; Marot A; Krawczyk M; Casper M; Lammert F; Eyer F; Vogel A; Marhenke S; von Felden J; Sharma R; Atkinson SR; McQuillin A; Nattermann J; Schafmayer C; Franke A; Strassburg C; Rietschel M; Altmann H; Sulk S; Thangapandi VR; Brosch M; Lackner C; Stauber RE; Canbay A; Link A; Reiberger T; Mandorfer M; Semmler G; Scheiner B; Datz C; Romeo S; Ginanni Corradini S; Irving WL; Morling JR; Guha IN; Barnes E; Ansari MA; Quistrebert J; Valenti L; Müller SA; Morgan MY; Dufour JF; Trebicka J; Berg T; Deltenre P; Mueller S; Hampe J; Stickel F, 2022. Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study.  Gut.

de Franchis R; Bosch J; Garcia-Tsao G; Reiberger T; Ripoll C, 2022. Reply to: 'Management of portal hypertension in patients treated with atezolizumab and bevacizumab for hepatocellular carcinoma'.  J Hepatol 77(2):567-568

Jachs M; Schwarz C; Panzer M; Binter T; Aberle SW; Hartl L; Dax K; Aigner E; Stättermayer AF; Munda P; Graziadei I; Holzmann H; Trauner M; Zoller H; Gschwantler M; Mandorfer M; Reiberger T; Ferenci P, 2022. Response-guided long-term treatment of chronic hepatitis D patients with bulevirtide-results of a "real world" study.  Aliment Pharmacol Ther 56(1):144-154

Semmler G; Lindorfer A; Schäfer B; Bartl S; Hametner-Schreil S; Gensluckner S; Balcar L; Pomej K; Lampichler K; Trauner M; Aigner E; Datz C; Zoller H; Hofer H; Schöfl R; Mandorfer M; Reiberger T; Scheiner B, 2022. Outcome of Budd-Chiari Syndrome Patients Treated With Direct Oral Anticoagulants: An Austrian Multicenter Study.  Clin Gastroenterol Hepatol.

Hartl L; Haslinger K; Angerer M; Semmler G; Schneeweiss-Gleixner M; Jachs M; Simbrunner B; Bauer DJM; Eigenbauer E; Strassl R; Breuer M; Kimberger O; Laxar D; Lampichler K; Halilbasic E; Stättermayer AF; Ba-Ssalamah A; Mandorfer M; Scheiner B; Reiberger T; Trauner M, 2022. Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease.  Hepatology.

Bastati N; Beer L; Ba-Ssalamah A; Poetter-Lang S; Ambros R; Kristic A; Lauber D; Pomej K; Binter T; Simbrunner B; Semmler G; Balcar L; Bican Y; Hodge JC; Wrba T; Trauner M; Reiberger T; Mandorfer M, 2022. Gadoxetic acid-enhanced MRI-derived functional liver imaging score (FLIS) and spleen diameter predict outcomes in ACLD.  J Hepatol 77(4):1005-1013

de Franchis R; Bosch J; Garcia-Tsao G; Reiberger T; Ripoll C, 2022. Corrigendum to 'Baveno VII - Renewing consensus in portal hypertension' [J Hepatol (2022) 959-974].  J Hepatol 77(1):271

Hofer BS; Simbrunner B; Bauer DJM; Paternostro R; Schwabl P; Scheiner B; Semmler G; Hartl L; Jachs M; Datterl B; Staettermayer AF; Trauner M; Mandorfer M; Reiberger T, 2022. Acute hemodynamic response to propranolol predicts bleeding and nonbleeding decompensation in patients with cirrhosis.  Hepatol Commun 6(9):2569-2580

Hartl L; Reiberger T; Trauner M, 2022. Reply.  Hepatology.

Simbrunner B; Villesen IF; Königshofer P; Scheiner B; Bauer D; Paternostro R; Schwabl P; Timelthaler G; Ramazanova D; Wöran K; Stift J; Eigenbauer E; Stättermayer AF; Marculescu R; Pinter M; Møller S; Trauner M; Karsdal M; Leeming DJ; Reiberger T; Mandorfer M, 2022. Systemic inflammation is linked to liver fibrogenesis in patients with advanced chronic liver disease.  Liver Int 42(11):2501-2512

Semmler G; Thorhauge KH; Reiberger T; Thiele M, 2022. Letter to the editor: Change in serial liver stiffness measurement by magnetic resonance elastography and outcomes in NAFLD.  Hepatology.

Raeven P; Mandorfer M; Baron DM; Reiberger T; Simbrunner B, 2021. Author's reply to "Thromboelastometry in patients with advanced chronic liver disease: a complex interplay".  Hepatol Int 15(2):522-524

Costa D; Simbrunner B; Reiberger T, 2021. Reply to: "Prognostic role of systemic inflammatory biomarkers in advanced chronic liver disease".  J Hepatol 74(4):1000-1001

Schwabl P; Hambruch E; Budas GR; Supper P; Burnet M; Liles JT; Birkel M; Brusilovskaya K; Königshofer P; Peck-Radosavljevic M; Watkins WJ; Trauner M; Breckenridge DG; Kremoser C; Reiberger T, 2021. The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH Model.  Biomedicines 9.

Steininger L; Chromy D; Bauer D; Simbrunner B; Binter T; Schwabl P; Schmidbauer C; Trauner M; Gschwantler M; Mandorfer M; Reiberger T, 2021. Direct patient-physician communication via a hepatitis C hotline facilitates treatment initiation in patients with poor adherence.  Wien Klin Wochenschr 133(9-10):452-460

Semmler G; Reiberger T, 2021. Letter to Lavian and colleagues.  Eur J Radiol 134:109449

Haslacher H; Rappel R; Thalhammer R; Demyanets S; Simbrunner B; Reiberger T; Eberhard S; Schwarzinger I, 2021. Adequate scattergram interpretation increases the reliability of automated polymorphonuclear (pmn) cell counts from ascitic fluid of patients with liver cirrhosis.  Int J Lab Hematol 43(4):O176-O180

Paternostro R; Bardach C; Hofer BS; Scheiner B; Schwabl P; Asenbaum U; Ba-Ssalamah A; Scharitzer M; Bucscis T; Simbrunner B; Bauer D; Trauner M; Mandorfer M; Reiberger T; Lampichler K, 2021. Prognostic impact of sarcopenia in cirrhotic patients stratified by different severity of portal hypertension.  Liver Int 41(4):799-809

Costa D; Simbrunner B; Jachs M; Hartl L; Bauer D; Paternostro R; Schwabl P; Scheiner B; Stättermayer AF; Pinter M; Trauner M; Mandorfer M; Reiberger T, 2021. Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality.  J Hepatol 74(4):819-828

Pfisterer N; Schmidbauer C; Riedl F; Maieron A; Stadlbauer V; Hennlich B; Schwarzer R; Puespoek A; Bucsics T; Effenberger M; Bota S; Gschwantler M; Peck-Radosavljevic M; Mandorfer M; Madl C; Trauner M; Reiberger T, 2021. Perceptions on the management of varices and on the use of albumin in patients with cirrhosis among GI specialists in Austria.  Wien Klin Wochenschr 133(9-10):421-431

Trebicka J; Fernandez J; Papp M; Caraceni P; Laleman W; Gambino C; Giovo I; Uschner FE; Jansen C; Jimenez C; Mookerjee R; Gustot T; Albillos A; Bañares R; Jarcuska P; Steib C; Reiberger T; Acevedo J; Gatti P; Shawcross DL; Zeuzem S; Zipprich A; Piano S; Berg T; Bruns T; Danielsen KV; Coenraad M; Merli M; Stauber R; Zoller H; Ramos JP; Solé C; Soriano G; de Gottardi A; Gronbaek H; Saliba F; Trautwein C; Kani HT; Francque S; Ryder S; Nahon P; Romero-Gomez M; Van Vlierberghe H; Francoz C; Manns M; Garcia-Lopez E; Tufoni M; Amoros A; Pavesi M; Sanchez C; Praktiknjo M; Curto A; Pitarch C; Putignano A; Moreno E; Bernal W; Aguilar F; Clària J; Ponzo P; Vitalis Z; Zaccherini G; Balogh B; Gerbes A; Vargas V; Alessandria C; Bernardi M; Ginès P; Moreau R; Angeli P; Jalan R; Arroyo V, 2021. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis.  J Hepatol 74(5):1097-1108

Jachs M; Hartl L; Schaufler D; Desbalmes C; Simbrunner B; Eigenbauer E; Bauer DJM; Paternostro R; Schwabl P; Scheiner B; Bucsics T; Stättermayer AF; Pinter M; Trauner M; Mandorfer M; Reiberger T, 2021. Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes.  Gut 70(9):1758-1767

Weiss E; Saner F; Asrani SK; Biancofiore G; Blasi A; Lerut J; Durand F; Fernandez J; Findlay JY; Fondevila C; Francoz C; Gustot T; Jaber S; Karvellas C; Kronish K; Laleman W; Laterre PF; Levesque E; Mandell MS; Mc Phail M; Muiesan P; Olson JC; Olthoff K; Daniele Pinna A; Reiberger T; Reyntjens K; Saliba F; Scatton O; Simpson KJ; Soubrane O; Subramanian RM; Tacke F; Tomescu D; Xia V; Wagener G; Paugam-Burtz C, 2021. When Is a Critically Ill Cirrhotic Patient Too Sick to Transplant? Development of Consensus Criteria by a Multidisciplinary Panel of 35 International Experts.  Transplantation 105(3):561-568

Beer L; Bastati N; Ba-Ssalamah A; Mandorfer M; Reiberger T, 2021. Author response to Letter to the Editor: MRI-defined sarcopenia predicts mortality in patients with chronic liver disease.  Liver Int 41(1):221-222

Simbrunner B; Stadlmann A; Schwabl P; Paternostro R; Bauer DJM; Bucsics T; Scheiner B; Lampichler K; Wöran K; Beer A; Eigenbauer E; Pinter M; Stättermayer AF; Marculescu R; Szekeres T; Trauner M; Mandorfer M; Reiberger T, 2021. Placental growth factor levels neither reflect severity of portal hypertension nor portal-hypertensive gastropathy in patients with advanced chronic liver disease.  Dig Liver Dis 53(3):345-352

Bauer D; Farthofer A; Chromy D; Simbrunner B; Steininger L; Schmidbauer C; Binter T; Trauner M; Mandorfer M; Schmidt R; Mayer F; Holzmann H; Strassl R; Reiberger T, 2021. Recent outbreaks of severe hepatitis A virus infections in Vienna.  Eur J Clin Microbiol Infect Dis 40(2):335-344

Semmler G; Binter T; Kozbial K; Schwabl P; Hametner-Schreil S; Zanetto A; Gavasso S; Chromy D; Bauer DJM; Simbrunner B; Scheiner B; Bucsics T; Stättermayer AF; Pinter M; Steindl-Munda P; Schöfl R; Russo FP; Simioni P; Trauner M; Ferenci P; Reiberger T; Mandorfer M, 2021. Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease.  Hepatology 73(4):1275-1289

Jachs M; Reiberger T, 2021. Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers: A Tailored Approach.  Clin Liver Dis 25(2):311-326

Reiberger T; Mandorfer M, 2021. Letter to the Editor: Perioperative Presentation of COVID-19 in a Liver Transplant Recipient.  Hepatology 73(2):868-869

Starlinger P; Ahn JC; Mullan A; Gyoeri GP; Pereyra D; Alva-Ruiz R; Hackl H; Reiberger T; Trauner M; Santol J; Simbrunner B; Mandorfer M; Berlakovich G; Kamath PS; Heimbach J, 2021. The Addition of C-Reactive Protein and von Willebrand Factor to Model for End-Stage Liver Disease-Sodium Improves Prediction of Waitlist Mortality.  Hepatology 74(3):1533-1545

Pons M; Augustin S; Scheiner B; Guillaume M; Rosselli M; Rodrigues SG; Stefanescu H; Ma MM; Mandorfer M; Mergeay-Fabre M; Procopet B; Schwabl P; Ferlitsch A; Semmler G; Berzigotti A; Tsochatzis E; Bureau C; Reiberger T; Bosch J; Abraldes JG; Genescà J, 2021. Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.  Am J Gastroenterol 116(4):723-732

Eder M; Omic H; Gorges J; Badt F; Kikic Z; Saemann MD; Tong A; Bauer D; Semmler G; Reiberger T; Lagler H; Scheiner B, 2021. Influenza vaccination uptake and factors influencing vaccination decision among patients with chronic kidney or liver disease.  PLoS One 16(4):e0249785

Hartl L; Semmler G; Hofer BS; Schirwani N; Jachs M; Simbrunner B; Bauer DJM; Binter T; Pomej K; Pinter M; Trauner M; Mandorfer M; Reiberger T; Scheiner B, 2021. COVID-19-Related Downscaling of In-Hospital Liver Care Decreased Patient Satisfaction and Increased Liver-Related Mortality.  Hepatol Commun 5(10):1660-1675

Simbrunner B; Costa D; Reiberger T, 2021. Reply to: "Presepsin as a biomarker of inflammation and prognosis in decompensated liver disease".  J Hepatol 75(1):234-236

Pomej K; Balcar L; Scheiner B; Semmler G; Meischl T; Mandorfer M; Reiberger T; Müller C; Trauner M; Pinter M, 2021. Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib.  J Hepatocell Carcinoma 8:1485-1493

Jachs M; Binter T; Schmidbauer C; Hartl L; Strasser M; Laferl H; Hametner-Schreil S; Lindorfer A; Dax K; Stauber RE; Kessler HH; Bernhofer S; Maieron A; Loacker L; Bota S; Santonja I; Munda P; Mandorfer M; Peck-Radosavljevic M; Holzmann H; Gschwantler M; Zoller H; Ferenci P; Reiberger T, 2021. Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosis.  United European Gastroenterol J 9(10):1119-1127

Simbrunner B; Trauner M; Reiberger T, 2021. Review article: therapeutic aspects of bile acid signalling in the gut-liver axis.  Aliment Pharmacol Ther 54(10):1243-1262

Pomej K; Scheiner B; Hartl L; Balcar L; Meischl T; Mandorfer M; Reiberger T; Müller C; Trauner M; Pinter M, 2021. COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospital.  PLoS One 16(8):e0256544

Pfisterer N; Unger LW; Reiberger T, 2021. Clinical algorithms for the prevention of variceal bleeding and rebleeding in patients with liver cirrhosis.  World J Hepatol 13(7):731-746

Semmler G; Datz C; Reiberger T; Trauner M, 2021. Diet and exercise in NAFLD/NASH: Beyond the obvious.  Liver Int 41(10):2249-2268

Schmidbauer C; Chromy D; Schmidbauer VU; Schwarz M; Jachs M; Bauer DJM; Binter T; Apata M; Nguyen DT; Mandorfer M; Simbrunner B; Rieger A; Mayer F; Breuer M; Strassl R; Schmidt R; Holzmann H; Trauner M; Gschwantler M; Reiberger T, 2021. Epidemiological trends of HBV and HDV coinfection among Viennese HIV+ patients.  Liver Int 41(11):2622-2634

Sladky VC; Eichin F; Reiberger T; Villunger A, 2021. Polyploidy control in hepatic health and disease.  J Hepatol 75(5):1177-1191

Königshofer P; Brusilovskaya K; Petrenko O; Hofer BS; Schwabl P; Trauner M; Reiberger T, 2021. Nuclear receptors in liver fibrosis.  Biochim Biophys Acta Mol Basis Dis 1867(12):166235

Jachs M; Binter T; Chromy D; Schalk H; Pichler K; Bauer D; Simbrunner B; Hartl L; Schmidbauer C; Mayer F; Strassl R; Mandorfer M; Gschwantler M; Reiberger T, 2021. Outcomes of an HCV elimination program targeting the Viennese MSM population.  Wien Klin Wochenschr 133(13-14):635-640

Hartl L; Elias J; Prager G; Reiberger T; Unger LW, 2021. Individualized treatment options for patients with non-cirrhotic and cirrhotic liver disease.  World J Gastroenterol 27(19):2281-2298

Semmler G; Pomej K; Bauer DJM; Balcar L; Simbrunner B; Binter T; Hartl L; Becker J; Pinter M; Quehenberger P; Trauner M; Mandorfer M; Lisman T; Reiberger T; Scheiner B, 2021. Safety of direct oral anticoagulants in patients with advanced liver disease.  Liver Int 41(9):2159-2170

Semmler G; Binter T; Kozbial K; Schwabl P; Chromy D; Bauer D; Simbrunner B; Müllner-Bucsics T; Scheiner B; Stättermayer A; Pinter M; Steindl-Munda P; Trauner M; Ferenci P; Reiberger T; Mandorfer M, 2021. Influence of Genetic Variants on Disease Regression and Outcomes in HCV-Related Advanced Chronic Liver Disease after SVR.  J Pers Med 11.

Simbrunner B; Trauner M; Reiberger T; Mandorfer M, 2021. Recent advances in the understanding and management of hepatorenal syndrome.  Fac Rev 10:48

Hartl L; Jachs M; Simbrunner B; Bauer DJM; Semmler G; Gompelmann D; Szekeres T; Quehenberger P; Trauner M; Mandorfer M; Scheiner B; Reiberger T, 2021. Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19.  J Pers Med 11.

Schmidbauer C; Schwarz M; Schütz A; Schubert R; Schwanke C; Gutic E; Pirker R; Lang T; Reiberger T; Haltmayer H; Gschwantler M, 2021. Directly observed therapy at opioid substitution facilities using sofosbuvir/velpatasvir results in excellent SVR12 rates in PWIDs at high risk for non-adherence to DAA therapy.  PLoS One 16(6):e0252274

Balcar L; Semmler G; Pomej K; Simbrunner B; Bauer D; Hartl L; Jachs M; Paternostro R; Bucsics T; Pinter M; Trauner M; Mandorfer M; Reiberger T; Scheiner B, 2021. Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute-on-chronic liver failure.  United European Gastroenterol J 9(4):427-437

Hartl L; Jachs M; Desbalmes C; Schaufler D; Simbrunner B; Paternostro R; Schwabl P; Bauer DJM; Semmler G; Scheiner B; Bucsics T; Eigenbauer E; Marculescu R; Szekeres T; Peck-Radosavljevic M; Kastl S; Trauner M; Mandorfer M; Reiberger T, 2021. The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomes.  Hepatol Int 15(5):1160-1173

Schmidbauer C; Chromy D; Schmidbauer V; Bauer D; Apata M; Nguyen D; Mandorfer M; Simbrunner B; Rieger A; Mayer F; Schmidt R; Holzmann H; Trauner M; Gschwantler M; Reiberger T, 2020. Epidemiological trends in HCV transmission and prevalence in the Viennese HIV+ population.  Liver Int 40(4):787-796

Scheiner B; Stättermayer AF; Schwabl P; Bucsics T; Paternostro R; Bauer D; Simbrunner B; Schmidt R; Marculescu R; Ferlitsch A; Peck-Radosavljevic M; Pinter M; Trauner M; Reiberger T; Ferenci P; Mandorfer M, 2020. Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension.  Liver Int 40(2):393-404

Praktiknjo M; Simón-Talero M; Römer J; Roccarina D; Martínez J; Lampichler K; Baiges A; Low G; Llop E; Maurer MH; Zipprich A; Triolo M; Maleux G; Fialla AD; Dam C; Vidal-González J; Majumdar A; Picón C; Toth D; Darnell A; Abraldes JG; López M; Jansen C; Chang J; Schierwagen R; Uschner F; Kukuk G; Meyer C; Thomas D; Wolter K; Strassburg CP; Laleman W; La Mura V; Ripoll C; Berzigotti A; Calleja JL; Tandon P; Hernandez-Gea V; Reiberger T; Albillos A; Tsochatzis EA; Krag A; Genescà J; Trebicka J, 2020. Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis.  J Hepatol 72(6):1140-1150

Simbrunner B; Beer A; Wöran K; Schmitz F; Primas C; Wewalka M; Pinter M; Dolak W; Scheiner B; Puespoek A; Trauner M; Oberhuber G; Mandorfer M; Reiberger T, 2020. Portal hypertensive gastropathy is associated with iron deficiency anemia.  Wien Klin Wochenschr 132(1-2):1-11

Schwarzer R; Reiberger T; Mandorfer M; Kivaranovic D; Hametner S; Hametner S; Paternostro R; Scheiner B; Schneeweiss-Friedl J; Trauner M; Schoefl R; Maieron A, 2020. The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis.  J Gastroenterol 55(5):533-542

Paternostro R; Pfeiffenberger J; Ferenci P; Stättermayer AF; Stauber RE; Wrba F; Longerich T; Lackner K; Trauner M; Ferlitsch A; Reiberger T; Weiss KH, 2020. Non-invasive diagnosis of cirrhosis and long-term disease monitoring by transient elastography in patients with Wilson disease.  Liver Int 40(4):894-904

Unger LW; Forstner B; Muckenhuber M; Scheuba K; Eigenbauer E; Scheiner B; Pfisterer N; Paternostro R; Trauner M; Mandorfer M; Reiberger T, 2020. Hepatic Steatosis in Lean Patients: Risk Factors and Impact on Mortality.  Dig Dis Sci 65(9):2712-2718

Mandorfer M; Kozbial K; Schwabl P; Chromy D; Semmler G; Stättermayer AF; Pinter M; Hernández-Gea V; Fritzer-Szekeres M; Steindl-Munda P; Trauner M; Peck-Radosavljevic M; García-Pagán JC; Ferenci P; Reiberger T, 2020. Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon-Free Therapy.  Hepatology 71(3):1023-1036

Györi GP; Pereyra D; Rumpf B; Hackl H; Köditz C; Ortmayr G; Reiberger T; Trauner M; Berlakovich GA; Starlinger P, 2020. The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver Transplantation.  Hepatology 72(2):584-594

Bastati N; Beer L; Mandorfer M; Poetter-Lang S; Tamandl D; Bican Y; Elmer MC; Einspieler H; Semmler G; Simbrunner B; Weber M; Hodge JC; Vernuccio F; Sirlin C; Reiberger T; Ba-Ssalamah A, 2020. Does the Functional Liver Imaging Score Derived from Gadoxetic Acid-enhanced MRI Predict Outcomes in Chronic Liver Disease?  Radiology 294(1):98-107

Mandorfer M; Peck-Radosavljevic M; Ferenci P; Reiberger T, 2020. Dynamics of platelet count after sustained virologic response do not mirror those of hepatic venous pressure gradient.  Liver Int 40(4):988-989

Trieb M; Rainer F; Stadlbauer V; Douschan P; Horvath A; Binder L; Trakaki A; Knuplez E; Scharnagl H; Stojakovic T; Heinemann Á; Mandorfer M; Paternostro R; Reiberger T; Pitarch C; Amorós A; Gerbes A; Caraceni P; Alessandria C; Moreau R; Clària J; Marsche G; Stauber RE, 2020. HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure.  J Hepatol 73(1):113-120

Chromy D; Schmidt R; Mandorfer M; Lang GF; Bauer D; Schwabl P; Popow-Kraupp T; Reiberger T; Mayer F, 2020. Hepatitis C Virus RNA Is Commonly Detectable in Rectal and Nasal Fluids of Patients With High Viremia.  Clin Infect Dis 71(5):1292-1299

Scheiner B; Semmler G; Maurer F; Schwabl P; Bucsics TA; Paternostro R; Bauer D; Simbrunner B; Trauner M; Mandorfer M; Reiberger T, 2020. Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease.  Liver Int 40(1):194-204

Scheiner B; Northup PG; Gruber AB; Semmler G; Leitner G; Quehenberger P; Thaler J; Ay C; Trauner M; Reiberger T; Lisman T; Mandorfer M, 2020. The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver disease.  Liver Int 40(6):1415-1426

Schneider CV; Hamesch K; Gross A; Mandorfer M; Moeller LS; Pereira V; Pons M; Kuca P; Reichert MC; Benini F; Burbaum B; Voss J; Gutberlet M; Woditsch V; Lindhauer C; Fromme M; Kümpers J; Bewersdorf L; Schaefer B; Eslam M; Bals R; Janciauskiene S; Carvão J; Neureiter D; Zhou B; Wöran K; Bantel H; Geier A; Dirrichs T; Stickel F; Teumer A; Verbeek J; Nevens F; Govaere O; Krawczyk M; Roskams T; Haybaeck J; Lurje G; Chorostowska-Wynimko J; Genesca J; Reiberger T; Lammert F; Krag A; George J; Anstee QM; Trauner M; Datz C; Gaisa NT; Denk H; Trautwein C; Aigner E; Strnad P, 2020. Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers.  Gastroenterology 159(2):534-548.e11

Schmidbauer C; Schubert R; Schütz A; Schwanke C; Luhn J; Gutic E; Pirker R; Lang T; Reiberger T; Haltmayer H; Gschwantler M, 2020. Directly observed therapy for HCV with glecaprevir/pibrentasvir alongside opioid substitution in people who inject drugs-First real world data from Austria.  PLoS One 15(3):e0229239

Stift J; Semmler G; Wöran K; Simbrunner B; Scheiner B; Schwabl P; Paternostro R; Pinter M; Stättermayer AF; Meischl T; Beer A; Trauner M; Mandorfer M; Reiberger T, 2020. Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy.  Dig Liver Dis 52(12):1473-1479

Simbrunner B; Semmler G; Stadlmann A; Scheiner B; Schwabl P; Paternostro R; Bucsics T; Bauer D; Eigenbauer E; Pinter M; Stättermayer AF; Quehenberger P; Marculescu R; Trauner M; Mandorfer M; Reiberger T, 2020. Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosis.  Hepatol Int 14(6):1093-1103

Hamesch K; Guldiken N; Aly M; Hüser N; Hartmann D; Rufat P; Ziol M; Remih K; Lurje G; Scheiner B; Trautwein C; Mandorfer M; Reiberger T; Mueller S; Bruns T; Nahon P; Strnad P, 2020. Serum keratin 19 (CYFRA21-1) links ductular reaction with portal hypertension and outcome of various advanced liver diseases.  BMC Med 18(1):336

Turco L; Villanueva C; La Mura V; García-Pagán JC; Reiberger T; Genescà J; Groszmann RJ; Sharma BC; Merkel C; Bureau C; Alvarado E; Abraldes JG; Albillos A; Bañares R; Peck-Radosavljevic M; Augustin S; Sarin SK; Bosch J; García-Tsao G, 2020. Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-Analysis.  Clin Gastroenterol Hepatol 18(2):313-327.e6

Pomej K; Scheiner B; Park D; Bauer D; Balcar L; Meischl T; Mandorfer M; Reiberger T; Müller C; Trauner M; Pinter M, 2020. Vascular Complications in Patients with Hepatocellular Carcinoma Treated with Sorafenib.  Cancers (Basel) 12.

Torres S; Abdullah Z; Brol MJ; Hellerbrand C; Fernandez M; Fiorotto R; Klein S; Königshofer P; Liedtke C; Lotersztajn S; Nevzorova YA; Schierwagen R; Reiberger T; Uschner FE; Tacke F; Weiskirchen R; Trebicka J, 2020. Recent Advances in Practical Methods for Liver Cell Biology: A Short Overview.  Int J Mol Sci 21.

Raeven P; Baron-Stefaniak J; Simbrunner B; Stadlmann A; Schwabl P; Scheiner B; Schaden E; Eigenbauer E; Quehenberger P; Mandorfer M; Baron DM; Reiberger T, 2020. Thromboelastometry in patients with advanced chronic liver disease stratified by severity of portal hypertension.  Hepatol Int 14(6):1083-1092

Sladky VC; Knapp K; Szabo TG; Braun VZ; Bongiovanni L; van den Bos H; Spierings DC; Westendorp B; Curinha A; Stojakovic T; Scharnagl H; Timelthaler G; Tsuchia K; Pinter M; Semmler G; Foijer F; de Bruin A; Reiberger T; Rohr-Udilova N; Villunger A, 2020. PIDDosome-induced p53-dependent ploidy restriction facilitates hepatocarcinogenesis.  EMBO Rep 21(12):e50893

Brusilovskaya K; Königshofer P; Lampach D; Szodl A; Supper P; Bauer D; Beer A; Stift J; Timelthaler G; Oberhuber G; Podesser BK; Seif M; Zinober K; Rohr-Udilova N; Trauner M; Reiberger T; Schwabl P, 2020. Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated rats.  United European Gastroenterol J 8(10):1174-1185

Beer L; Bastati N; Ba-Ssalamah A; Pötter-Lang S; Lampichler K; Bican Y; Lauber D; Hodge J; Binter T; Pomej K; Simbrunner B; Semmler G; Trauner M; Mandorfer M; Reiberger T, 2020. MRI-defined sarcopenia predicts mortality in patients with chronic liver disease.  Liver Int 40(11):2797-2807

Trebicka J; Fernandez J; Papp M; Caraceni P; Laleman W; Gambino C; Giovo I; Uschner FE; Jimenez C; Mookerjee R; Gustot T; Albillos A; Bañares R; Janicko M; Steib C; Reiberger T; Acevedo J; Gatti P; Bernal W; Zeuzem S; Zipprich A; Piano S; Berg T; Bruns T; Bendtsen F; Coenraad M; Merli M; Stauber R; Zoller H; Ramos JP; Solè C; Soriano G; de Gottardi A; Gronbaek H; Saliba F; Trautwein C; Özdogan OC; Francque S; Ryder S; Nahon P; Romero-Gomez M; Van Vlierberghe H; Francoz C; Manns M; Garcia E; Tufoni M; Amoros A; Pavesi M; Sanchez C; Curto A; Pitarch C; Putignano A; Moreno E; Shawcross D; Aguilar F; Clària J; Ponzo P; Jansen C; Vitalis Z; Zaccherini G; Balogh B; Vargas V; Montagnese S; Alessandria C; Bernardi M; Ginès P; Jalan R; Moreau R; Angeli P; Arroyo V, 2020. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology.  J Hepatol 73(4):842-854

Reiberger T; Schwabl P; Trauner M; Peck-Radosavljevic M; Mandorfer M, 2020. Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy.  J Vis Exp.

Uschner FE; Glückert K; Paternostro R; Gnad T; Schierwagen R; Mandorfer M; Magdaleno F; Ortiz C; Schwarzkopf K; Kamath PS; Alessandria C; Boesecke C; Pfeifer A; Reiberger T; Kreisel W; Sauerbruch T; Ferlitsch A; Trebicka J; Klein S, 2020. Combination of phosphodiesterase-5-inhibitors and beta blockers improves experimental portal hypertension and erectile dysfunction.  Liver Int 40(9):2228-2241

Mandorfer M; Hernández-Gea V; García-Pagán JC; Reiberger T, 2020. Noninvasive Diagnostics for Portal Hypertension: A Comprehensive Review.  Semin Liver Dis 40(3):240-255

Simbrunner B; Marculescu R; Scheiner B; Schwabl P; Bucsics T; Stadlmann A; Bauer DJM; Paternostro R; Eigenbauer E; Pinter M; Stättermayer AF; Trauner M; Mandorfer M; Reiberger T, 2020. Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease.  Liver Int 40(7):1713-1724

Semmler G; Wöran K; Scheiner B; Unger LW; Paternostro R; Stift J; Schwabl P; Bucsics T; Bauer D; Simbrunner B; Stättermayer AF; Pinter M; Trauner M; Reiberger T; Mandorfer M, 2020. Novel reliability criteria for controlled attenuation parameter assessments for non-invasive evaluation of hepatic steatosis.  United European Gastroenterol J 8(3):321-331

Semmler G; Simbrunner B; Scheiner B; Schwabl P; Paternostro R; Bucsics T; Stättermayer AF; Bauer D; Pinter M; Ferenci P; Trauner M; Mandorfer M; Reiberger T, 2019. Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertension.  J Gastroenterol Hepatol 34(12):2164-2172

Chromy D; Mandorfer M; Bucsics T; Schwabl P; Bauer D; Scheiner B; Schmidbauer C; Lang GF; Szekeres T; Ferenci P; Trauner M; Reiberger T, 2019. Prevalence and Predictors of Hepatic Steatosis in Patients with HIV/HCV Coinfection and the Impact of HCV Eradication.  AIDS Patient Care STDS 33(5):197-206

Chromy D; Mandorfer M; Bucsics T; Schwabl P; Scheiner B; Schmidbauer C; Aichelburg MC; Ferenci P; Trauner M; Peck-Radosavljevic M; Reiberger T, 2019. High efficacy of interferon-free therapy for acute hepatitis C in HIV-positive patients.  United European Gastroenterol J 7(4):507-516

Hamesch K; Mandorfer M; Pereira VM; Moeller LS; Pons M; Dolman GE; Reichert MC; Schneider CV; Woditsch V; Voss J; Lindhauer C; Fromme M; Spivak I; Guldiken N; Zhou B; Arslanow A; Schaefer B; Zoller H; Aigner E; Reiberger T; Wetzel M; Siegmund B; Simões C; Gaspar R; Maia L; Costa D; Bento-Miranda M; van Helden J; Yagmur E; Bzdok D; Stolk J; Gleiber W; Knipel V; Windisch W; Mahadeva R; Bals R; Koczulla R; Barrecheguren M; Miravitlles M; Janciauskiene S; Stickel F; Lammert F; Liberal R; Genesca J; Griffiths WJ; Trauner M; Krag A; Trautwein C; Strnad P, 2019. Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation.  Gastroenterology 157(3):705-719.e18

Paternostro R; Heinisch BB; Reiberger T; Mandorfer M; Bardach C; Lampichler K; Seeland B; Schwarzer R; Trauner M; Peck-Radosavljevic M; Ferlitsch A, 2019. Dysbalanced sex hormone status is an independent predictor of decompensation and mortality in patients with liver cirrhosis.  Hepatol Res 49(2):201-211

Beer L; Mandorfer M; Bastati N; Poetter-Lang S; Tamandl D; Stoyanova DP; Elmer MC; Semmler G; Simbrunner B; Hodge JC; Sirlin CB; Reiberger T; Ba-Ssalamah A, 2019. Inter- and intra-reader agreement for gadoxetic acid-enhanced MRI parameter readings in patients with chronic liver diseases.  Eur Radiol 29(12):6600-6610

Stift J; Semmler G; Walzel C; Mandorfer M; Schwarzer R; Schwabl P; Paternostro R; Scheiner B; Wöran K; Pinter M; Stättermayer AF; Trauner M; Peck-Radosavljevic M; Ferlitsch A; Reiberger T, 2019. Transjugular aspiration liver biopsy performed by hepatologists trained in HVPG measurements is safe and provides important diagnostic information.  Dig Liver Dis 51(8):1144-1151

Paternostro R; Reiberger T; Bucsics T, 2019. Elastography-based screening for esophageal varices in patients with advanced chronic liver disease.  World J Gastroenterol 25(3):308-329

Pfisterer N; Riedl F; Pachofszky T; Gschwantler M; König K; Schuster B; Mandorfer M; Gessl I; Illiasch C; Fuchs EM; Unger L; Dolak W; Maieron A; Kramer L; Madl C; Trauner M; Reiberger T, 2019. Outcomes after placement of a SX-ELLA oesophageal stent for refractory variceal bleeding-A national multicentre study.  Liver Int 39(2):290-298

Scheiner B; Steininger L; Semmler G; Unger LW; Schwabl P; Bucsics T; Paternostro R; Ferlitsch A; Trauner M; Reiberger T; Mandorfer M, 2019. Controlled attenuation parameter does not predict hepatic decompensation in patients with advanced chronic liver disease.  Liver Int 39(1):127-135

Königshofer P; Brusilovskaya K; Schwabl P; Reiberger T, 2019. Animal models of portal hypertension.  Biochim Biophys Acta Mol Basis Dis 1865(5):1019-1030

Meischl T; Rasoul-Rockenschaub S; Györi G; Sieghart W; Reiberger T; Trauner M; Soliman T; Berlakovich G; Pinter M, 2019. C-reactive protein is an independent predictor for hepatocellular carcinoma recurrence after liver transplantation.  PLoS One 14(5):e0216677

Brusilovskaya K; Königshofer P; Schwabl P; Reiberger T, 2019. Vascular Targets for the Treatment of Portal Hypertension.  Semin Liver Dis 39(4):483-501

Scheiner B; Kirstein M; Popp S; Hucke F; Bota S; Rohr-Udilova N; Reiberger T; Müller C; Trauner M; Peck-Radosavljevic M; Vogel A; Sieghart W; Pinter M, 2019. Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma.  Liver Cancer 8(3):203-217

Simbrunner B; Röthenbacher A; Haslacher H; Bauer D; Chromy D; Bucsics T; Schwabl P; Paternostro R; Scheiner B; Trauner M; Mandorfer M; Schwarzinger I; Reiberger T, 2019. Ascitic fluid polymorphic nuclear cell count impacts on outcome of cirrhotic patients with ascites.  United European Gastroenterol J 7(5):651-661

Scheiner B; Ulbrich G; Mandorfer M; Reiberger T; Müller C; Waneck F; Trauner M; Kölblinger C; Ferlitsch A; Sieghart W; Peck-Radosavljevic M; Pinter M, 2019. Short- and long-term effects of transarterial chemoembolization on portal hypertension in patients with hepatocellular carcinoma.  United European Gastroenterol J 7(6):850-858

Unger LW; Forstner B; Schneglberger S; Muckenhuber M; Eigenbauer E; Bauer D; Scheiner B; Mandorfer M; Trauner M; Reiberger T, 2019. Guideline-conform statin use reduces overall mortality in patients with compensated liver disease.  Sci Rep 9(1):11674

Paternostro R; Lampichler K; Bardach C; Asenbaum U; Landler C; Bauer D; Mandorfer M; Schwarzer R; Trauner M; Reiberger T; Ferlitsch A, 2019. The value of different CT-based methods for diagnosing low muscle mass and predicting mortality in patients with cirrhosis.  Liver Int 39(12):2374-2385

Schwabl P; Köppel S; Königshofer P; Bucsics T; Trauner M; Reiberger T; Liebmann B, 2019. Detection of Various Microplastics in Human Stool: A Prospective Case Series.  Ann Intern Med 171(7):453-457

Unger LW; Forstner B; Schneglberger S; Muckenhuber M; Eigenbauer E; Scheiner B; Mandorfer M; Trauner M; Reiberger T, 2019. Patterns and prevalence of dyslipidemia in patients with different etiologies of chronic liver disease.  Wien Klin Wochenschr 131(17-18):395-403

Semmler G; Scheiner B; Schwabl P; Bucsics T; Paternostro R; Chromy D; Stättermayer AF; Trauner M; Mandorfer M; Ferlitsch A; Reiberger T, 2019. The impact of hepatic steatosis on portal hypertension.  PLoS One 14(11):e0224506

Dalos D; Binder C; Duca F; Aschauer S; Kammerlander A; Hengstenberg C; Mascherbauer J; Reiberger T; Bonderman D, 2019. Serum levels of gamma-glutamyltransferase predict outcome in heart failure with preserved ejection fraction.  Sci Rep 9(1):18541

Semmler G; Stift J; Scheiner B; Wöran K; Schwabl P; Paternostro R; Bucsics T; Stättermayer AF; Pinter M; Ferlitsch A; Trauner M; Reiberger T; Mandorfer M, 2019. Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension.  Dig Dis Sci 64(12):3642-3651

Mandorfer M; Reiberger T, 2019. Editorial: pressure to close the therapeutic window of non-selective beta blockers?  Aliment Pharmacol Ther 50(8):957-958

Simbrunner B; Mandorfer M; Trauner M; Reiberger T, 2019. Gut-liver axis signaling in portal hypertension.  World J Gastroenterol 25(39):5897-5917

Simón-Talero M; Roccarina D; Martínez J; Lampichler K; Baiges A; Low G; Llop E; Praktiknjo M; Maurer MH; Zipprich A; Triolo M; Vangrinsven G; Garcia-Martinez R; Dam A; Majumdar A; Picón C; Toth D; Darnell A; Abraldes JG; Lopez M; Kukuk G; Krag A; Bañares R; Laleman W; La Mura V; Ripoll C; Berzigotti A; Trebicka J; Calleja JL; Tandon P; Hernandez-Gea V; Reiberger T; Albillos A; Tsochatzis EA; Augustin S; Genescà J, 2018. Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.  Gastroenterology 154(6):1694-1705.e4

Bucsics T; Schoder M; Diermayr M; Feldner-Busztin M; Goeschl N; Bauer D; Schwabl P; Mandorfer M; Angermayr B; Cejna M; Ferlitsch A; Sieghart W; Trauner M; Peck-Radosavljevic M; Karner J; Karnel F; Reiberger T, 2018. Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding - A two decades experience.  PLoS One 13(1):e0189414

Pfisterer N; Dexheimer C; Fuchs EM; Bucsics T; Schwabl P; Mandorfer M; Gessl I; Sandrieser L; Baumann L; Riedl F; Scheiner B; Pachofszky T; Dolak W; Schrutka-Kölbl C; Ferlitsch A; Schöniger-Hekele M; Peck-Radosavljevic M; Trauner M; Madl C; Reiberger T, 2018. Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding.  Aliment Pharmacol Ther 47(7):966-979

Paternostro R; Heinisch BB; Reiberger T; Mandorfer M; Schwarzer R; Seeland B; Trauner M; Peck-Radosavljevic M; Ferlitsch A, 2018. Erectile dysfunction in cirrhosis is impacted by liver dysfunction, portal hypertension, diabetes and arterial hypertension.  Liver Int 38(8):1427-1436

Mandorfer M; Schwabl P; Paternostro R; Pomej K; Bauer D; Thaler J; Ay C; Quehenberger P; Fritzer-Szekeres M; Peck-Radosavljevic M; Trauner M; Reiberger T; Ferlitsch A, 2018. Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity.  Aliment Pharmacol Ther 47(7):980-988

Schwarzer R; Kivaranovic D; Paternostro R; Mandorfer M; Reiberger T; Trauner M; Peck-Radosavljevic M; Ferlitsch A, 2018. Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose-response study.  Aliment Pharmacol Ther 47(8):1162-1169

Lo GH; Reiberger T, 2018. Peptic ulcer bleeding in patients with cirrhosis: Is it as bad as variceal bleeding?  Hepatology 67(4):1219-1220

Schwarzer R; Kivaranovic D; Mandorfer M; Paternostro R; Wolrab D; Heinisch B; Reiberger T; Ferlitsch M; Gerner C; Trauner M; Peck-Radosavljevic M; Ferlitsch A, 2018. Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertension.  Aliment Pharmacol Ther 47(1):86-94

Viveiros A; Finkenstedt A; Schaefer B; Mandorfer M; Scheiner B; Lehner K; Tobiasch M; Reiberger T; Tilg H; Edlinger M; Zoller H, 2018. Transferrin as a predictor of survival in cirrhosis.  Liver Transpl 24(3):343-351

Starlinger P; Pereyra D; Haegele S; Braeuer P; Oehlberger L; Primavesi F; Kohler A; Offensperger F; Reiberger T; Ferlitsch A; Messner B; Beldi G; Staettner S; Brostjan C; Gruenberger T, 2018. Perioperative von Willebrand factor dynamics are associated with liver regeneration and predict outcome after liver resection.  Hepatology 67(4):1516-1530

Moser S; Kozbial K; Laferl H; Schütz A; Reiberger T; Schwabl P; Gutic E; Schwanke C; Schubert R; Luhn J; Lang T; Schleicher M; Steindl-Munda P; Haltmayer H; Ferenci P; Gschwantler M, 2018. Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver disease.  Eur J Gastroenterol Hepatol 30(3):291-295

Mandorfer M; Reiberger T, 2018. Role of diuretics in the harmful effects of beta blockers in patients with ascites. Author's reply.  Dig Liver Dis 50(1):102-103

Mandorfer M; Reiberger T; Peck-Radosavljevic M, 2018. Monitoring the Evolution of Portal Hypertension After Sustained Virologic Response.  Gastroenterology 154(5):1550-1551

Bucsics T; Hoffman S; Grünberger J; Schoder M; Matzek W; Stadlmann A; Mandorfer M; Schwabl P; Ferlitsch A; Peck-Radosavljevic M; Trauner M; Karner J; Karnel F; Reiberger T, 2018. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis.  Liver Int 38(6):1036-1044

Unger LW; Berlakovich GA; Trauner M; Reiberger T, 2018. Management of portal hypertension before and after liver transplantation.  Liver Transpl 24(1):112-121

Chromy D; Schwabl P; Bucsics T; Scheiner B; Strassl R; Mayer F; Aichelburg MC; Grabmeier-Pfistershammer K; Trauner M; Peck-Radosavljevic M; Reiberger T; Mandorfer M, 2018. Non-invasive liver fibrosis assessment and HCV treatment initiation within a systematic screening program in HIV/HCV coinfected patients.  Wien Klin Wochenschr 130(3-4):105-114

Rohr-Udilova N; Bauer E; Timelthaler G; Eferl R; Stolze K; Pinter M; Seif M; Hayden H; Reiberger T; Schulte-Hermann R; Peck-Radosavljevic M; Stoiber D; Trauner M, 2018. Impact of glutathione peroxidase 4 on cell proliferation, angiogenesis and cytokine production in hepatocellular carcinoma.  Oncotarget 9(11):10054-10068

Reiberger T; Ferlitsch A, 2018. Editorial: optimal dose of carvedilol in portal hypertension…nearly there. Authors' reply.  Aliment Pharmacol Ther 47(9):1329-1330

Pfisterer N; Mandorfer M; Reiberger T, 2018. Editorial: use of beta-blockers and band ligation in preventing first and recurrent variceal bleeding-"real life" vs evidence-based decisions. Authors' reply.  Aliment Pharmacol Ther 47(8):1224-1225

Mandorfer M; Scheiner B; Stättermayer AF; Schwabl P; Paternostro R; Bauer D; Schaefer B; Zoller H; Peck-Radosavljevic M; Trauner M; Reiberger T; Ferenci P; Ferlitsch A, 2018. Impact of patatin-like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension.  Aliment Pharmacol Ther 48(4):451-459

Reiberger T; Bucsics T; Paternostro R; Pfisterer N; Riedl F; Mandorfer M, 2018. Small Esophageal Varices in Patients with Cirrhosis-Should We Treat Them?  Curr Hepatol Rep 17(4):301-315

Steininger M; Winter MP; Reiberger T; Koller L; El-Hamid F; Forster S; Schnaubelt S; Hengstenberg C; Distelmaier K; Goliasch G; Wojta J; Toma A; Niessner A; Sulzgruber P, 2018. De-Ritis Ratio Improves Long-Term Risk Prediction after Acute Myocardial Infarction.  J Clin Med 7.

Trebicka J; Reiberger T; Laleman W, 2018. Gut-Liver Axis Links Portal Hypertension to Acute-on-Chronic Liver Failure.  Visc Med 34(4):270-275

Mandorfer M; Scheiner B; Reiberger T; Ferlitsch A, 2018. Editorial: surviving your genes-the role of PNPLA3 variation in end-stage liver disease. Authors' reply.  Aliment Pharmacol Ther 48(7):775-776

Bucsics T; Grasl B; Ferlitsch A; Schwabl P; Mandorfer M; Zinober K; Stern R; Chromy D; Scheiner B; Sieghart W; Peck-Radosavljevic M; Trauner M; Reiberger T, 2018. Point Shear Wave Elastography for Non-invasive Assessment of Liver Fibrosis in Patients with Viral Hepatitis.  Ultrasound Med Biol 44(12):2578-2586

Haider L; Mandorfer M; Güngören Z; Reiberger T; Bastati N; Hodge JC; Chromy D; Trauner M; Herold C; Peck-Radosavljevic M; Ba-Ssalamah A, 2018. Noninvasive Monitoring of Liver Disease Regression after Hepatitis C Eradication Using Gadoxetic Acid-Enhanced MRI.  Contrast Media Mol Imaging 2018:8489709

Mandorfer M; Bucsics T; Hutya V; Schmid-Scherzer K; Schaefer B; Zoller H; Ferlitsch A; Peck-Radosavljevic M; Trauner M; Ferenci P; Kneussl M; Reiberger T, 2018. Liver disease in adults with α1-antitrypsin deficiency.  United European Gastroenterol J 6(5):710-718

Königshofer P; Brusilovskaya K; Schwabl P; Podesser BK; Trauner M; Reiberger T, 2018. Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats.  J Vis Exp.

Schwabl P; Brusilovskaya K; Supper P; Bauer D; Königshofer P; Riedl F; Hayden H; Fuchs CD; Stift J; Oberhuber G; Aschauer S; Bonderman D; Gnad T; Pfeifer A; Uschner FE; Trebicka J; Rohr-Udilova N; Podesser BK; Peck-Radosavljevic M; Trauner M; Reiberger T, 2018. The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats.  Sci Rep 8(1):9372

Scheiner B; Stammet PR; Pokorny S; Bucsics T; Schwabl P; Brichta A; Thaler J; Lampichler K; Ba-Ssalamah A; Ay C; Ferlitsch A; Trauner M; Mandorfer M; Reiberger T, 2018. Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function.  Wien Klin Wochenschr 130(13-14):446-455

Mandorfer M; Reiberger T; Ferlitsch A, 2018. Editorial: von Willebrand factor and CRP levels may predict survival in liver cirrhosis-Authors' reply.  Aliment Pharmacol Ther 47(11):1537-1538

Piecha F; Mandorfer M; Peccerella T; Ozga AK; Poth T; Vonbank A; Seitz HK; Rausch V; Reiberger T; Mueller S, 2018. Pharmacological decrease of liver stiffness is pressure-related and predicts long-term clinical outcome.  Am J Physiol Gastrointest Liver Physiol 315(4):G484-G494

Ferraioli G; De Silvestri A; Reiberger T; Taylor-Robinson SD; de Knegt RJ; Maiocchi L; Mare R; Bucsics T; Atzori S; Tinelli C; Sporea I, 2018. Adherence to quality criteria improves concordance between transient elastography and ElastPQ for liver stiffness assessment-A multicenter retrospective study.  Dig Liver Dis 50(10):1056-1061

Reiberger T, 2018. When Should We Stop Treatment With Terlipressin and Albumin for Patients With Hepatorenal Syndrome?  Clin Gastroenterol Hepatol 16(11):1710-1711

Rohr-Udilova N; Klinglmüller F; Schulte-Hermann R; Stift J; Herac M; Salzmann M; Finotello F; Timelthaler G; Oberhuber G; Pinter M; Reiberger T; Jensen-Jarolim E; Eferl R; Trauner M, 2018. Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma.  Sci Rep 8(1):6220

Paternostro R; Reiberger T; Mandorfer M; Schwarzer R; Schwabl P; Bota S; Ferlitsch M; Trauner M; Peck-Radosavljevic M; Ferlitsch A, 2017. Plasma renin concentration represents an independent risk factor for mortality and is associated with liver dysfunction in patients with cirrhosis.  J Gastroenterol Hepatol 32(1):184-190

Schwabl P; Mandorfer M; Reiberger T, 2017. Editorial: direct acting antivirals - not the be-all and end-all in HIV/HCV co-infection. Authors' reply.  Aliment Pharmacol Ther 45(4):570-571

Fuchs CD; Paumgartner G; Wahlström A; Schwabl P; Reiberger T; Leditznig N; Stojakovic T; Rohr-Udilova N; Chiba P; Marschall HU; Trauner M, 2017. Metabolic preconditioning protects BSEP/ABCB11-/- mice against cholestatic liver injury.  J Hepatol 66(1):95-101

Mandorfer M; Peck-Radosavljevic M; Reiberger T, 2017. Prevention of progression from small to large varices: are we there yet? An updated meta-analysis.  Gut 66(7):1347-1349

Reiberger T; Mandorfer M, 2017. Beta adrenergic blockade and decompensated cirrhosis.  J Hepatol 66(4):849-859

Paternostro R; Wagner D; Reiberger T; Mandorfer M; Schwarzer R; Ferlitsch M; Trauner M; Peck-Radosavljevic M; Ferlitsch A, 2017. Low 25-OH-vitamin D levels reflect hepatic dysfunction and are associated with mortality in patients with liver cirrhosis.  Wien Klin Wochenschr 129(1-2):8-15

Schwabl P; Mandorfer M; Steiner S; Scheiner B; Chromy D; Herac M; Bucsics T; Hayden H; Grabmeier-Pfistershammer K; Ferlitsch A; Oberhuber G; Trauner M; Peck-Radosavljevic M; Reiberger T, 2017. Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease.  Aliment Pharmacol Ther 45(1):139-149

Unger LW; Herac M; Staufer K; Salat A; Silberhumer G; Hofmann M; Trauner M; Rasoul-Rockenschaub S; Soliman T; Reiberger T; Berlakovich GA, 2017. The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case-control study.  Eur J Gastroenterol Hepatol 29(3):309-316

Schwabl P; Hambruch E; Seeland BA; Hayden H; Wagner M; Garnys L; Strobel B; Schubert TL; Riedl F; Mitteregger D; Burnet M; Starlinger P; Oberhuber G; Deuschle U; Rohr-Udilova N; Podesser BK; Peck-Radosavljevic M; Reiberger T; Kremoser C; Trauner M, 2017. The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction.  J Hepatol 66(4):724-733

Mandorfer M; Reiberger T, 2017. Beta blockers and cirrhosis, 2016.  Dig Liver Dis 49(1):3-10

Steiner S; Bucsics T; Schwabl P; Mandorfer M; Scheiner B; Aichelburg MC; Grabmeier-Pfistershammer K; Ferenci P; Trauner M; Peck-Radosavljevic M; Reiberger T, 2017. Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna.  Wien Klin Wochenschr 129(15-16):517-526

Unger LW; Stork T; Bucsics T; Rasoul-Rockenschaub S; Staufer K; Trauner M; Maschke S; Pawloff M; Soliman T; Reiberger T; Berlakovich GA, 2017. The role of TIPS in the management of liver transplant candidates.  United European Gastroenterol J 5(8):1100-1107

Reiberger T; Trebicka J, 2017. New liver - Fresh microbiome: Implications on brain function.  Liver Transpl 23(7):873-874

Scheiner B; Parada-Rodriguez D; Bucsics T; Schwabl P; Mandorfer M; Pfisterer N; Riedl F; Sieghart W; Ferlitsch A; Trauner M; Peck-Radosavljevic M; Reiberger T, 2017. Non-selective beta-blocker treatment does not impact on kidney function in cirrhotic patients with varices.  Scand J Gastroenterol 52(9):1008-1015

Reiberger T; Mandorfer M, 2017. Reply to: "Beta adrenergic blockade and advanced cirrhosis: Does it really improve survival in patients with acute-on-chronic liver failure?"  J Hepatol 67(4):880-881

Asenbaum U; Ba-Ssalamah A; Mandorfer M; Nolz R; Furtner J; Reiberger T; Ferlitsch A; Kaczirek K; Trauner M; Peck-Radosavljevic M; Wibmer AG, 2017. Effects of Portal Hypertension on Gadoxetic Acid-Enhanced Liver Magnetic Resonance: Diagnostic and Prognostic Implications.  Invest Radiol 52(8):462-469

Scheiner B; Lindner G; Reiberger T; Schneeweiss B; Trauner M; Zauner C; Funk GC, 2017. Acid-base disorders in liver disease.  J Hepatol 67(5):1062-1073

Mandorfer M; Schwabl P; Peck-Radosavljevic M; Reiberger T, 2017. Letter: sustained virological response and liver healing - authors' reply.  Aliment Pharmacol Ther 45(8):1173-1174

Mandorfer M; Reiberger T, 2017. Reply to: "Non selective beta blockers in cirrhosis".  J Hepatol 67(6):1343-1344

Bucsics T; Schoder M; Goeschl N; Schwabl P; Mandorfer M; Diermayr M; Feldner M; Riedl F; Bauer D; Angermayr B; Cejna M; Ferlitsch A; Sieghart W; Trauner M; Peck-Radosavljevic M; Karner J; Karnel F; Reiberger T, 2017. Re-bleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practice.  Dig Liver Dis 49(12):1360-1367

Reiberger T; Püspök A; Schoder M; Baumann-Durchschein F; Bucsics T; Datz C; Dolak W; Ferlitsch A; Finkenstedt A; Graziadei I; Hametner S; Karnel F; Krones E; Maieron A; Mandorfer M; Peck-Radosavljevic M; Rainer F; Schwabl P; Stadlbauer V; Stauber R; Tilg H; Trauner M; Zoller H; Schöfl R; Fickert P, 2017. Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III).  Wien Klin Wochenschr 129(Suppl 3):135-158

Starlinger P; Haegele S; Offensperger F; Oehlberger L; Pereyra D; Kral JB; Schrottmaier WC; Badrnya S; Reiberger T; Ferlitsch A; Stift J; Luf F; Brostjan C; Gruenberger T; Assinger A, 2016. The profile of platelet α-granule released molecules affects postoperative liver regeneration.  Hepatology 63(5):1675-88

Handisurya A; Kerscher C; Tura A; Herkner H; Payer BA; Mandorfer M; Werzowa J; Winnicki W; Reiberger T; Kautzky-Willer A; Pacini G; Säemann M; Schmidt A, 2016. Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients.  PLoS One 11(1):e0145319

Mandorfer M; Schwabl P; Steiner S; Reiberger T; Peck-Radosavljevic M, 2016. Advances in the management of HIV/HCV coinfection.  Hepatol Int 10(3):424-35

Mandorfer M; Schwabl P; Steiner S; Scheiner B; Chromy D; Bucsics T; Stättermayer AF; Aichelburg MC; Grabmeier-Pfistershammer K; Trauner M; Reiberger T; Peck-Radosavljevic M, 2016. Interferon-free treatment with sofosbuvir/daclatasvir achieves sustained virologic response in 100% of HIV/hepatitis C virus-coinfected patients with advanced liver disease.  AIDS 30(7):1039-47

Trebicka J; von Heydebrand M; Lehmann J; Tofteng F; Busk T; Jensen HL; Rohde J; Reiberger T; Mortensen C; Schierwagen R; Klein S; Møller S; Bendtsen F; Krag A, 2016. Assessment of response to beta-blockers by expression of βArr2 and RhoA/ROCK2 in antrum mucosa in cirrhotic patients.  J Hepatol 64(6):1265-73

Mandorfer M; Steiner S; Schwabl P; Payer BA; Aichelburg MC; Grabmeier-Pfistershammer K; Trauner M; Reiberger T; Peck-Radosavljevic M, 2016. Treatment intensification with boceprevir in HIV-positive patients with acute HCV-genotype 1 infection at high risk for treatment failure.  Wien Klin Wochenschr 128(11-12):414-20

Herout S; Mandorfer M; Breitenecker F; Reiberger T; Grabmeier-Pfistershammer K; Rieger A; Aichelburg MC, 2016. Impact of Early Initiation of Antiretroviral Therapy in Patients with Acute HIV Infection in Vienna, Austria.  PLoS One 11(4):e0152910

Bucsics T; Schwabl P; Mandorfer M; Bota S; Sieghart W; Ferlitsch A; Trauner M; Reiberger T; Peck-Radosavljevic M, 2016. The trigger matters - outcome of hepatorenal syndrome vs. specifically triggered acute kidney injury in cirrhotic patients with ascites.  Liver Int 36(11):1649-1656

Mandorfer M; Kozbial K; Schwabl P; Freissmuth C; Schwarzer R; Stern R; Chromy D; Stättermayer AF; Reiberger T; Beinhardt S; Sieghart W; Trauner M; Hofer H; Ferlitsch A; Ferenci P; Peck-Radosavljevic M, 2016. Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension.  J Hepatol 65(4):692-699

Scheiner B; Schwabl P; Steiner S; Bucsics T; Chromy D; Aichelburg MC; Grabmeier-Pfistershammer K; Trauner M; Peck-Radosavljevic M; Reiberger T; Mandorfer M, 2016. Interferon-free regimens improve health-related quality of life and fatigue in HIV/HCV-coinfected patients with advanced liver disease: A retrospective study.  Medicine (Baltimore) 95(27):e4061

Rutter K; Etschmaier A; Ferlitsch M; Maieron A; Hametner S; Horvatits T; Paternostro R; Salzl P; Reiberger T; Peck-Radosavljevic M; Quehenberger P; Hofer H; Trauner M; Ferenci P; Ferlitsch A, 2016. von Willebrand factor antigen (vWF-Ag): A non-invasive predictor of treatment response and serious adverse events in HCV patients with interferon triple therapy.  Dig Liver Dis 48(10):1194-9

Mandorfer M; Reiberger T, 2016. Nonselective beta blockers in patients with ascites: implications of a nationwide study.  Liver Int 36(9):1255-7

Fuchs CD; Schwabl P; Reiberger T; Trauner M, 2016. Liver Capsule: FXR agonists against liver disease.  Hepatology 64(5):1773

Mandorfer M; Payer BA; Schwabl P; Steiner S; Ferlitsch A; Aichelburg MC; Stättermayer AF; Ferenci P; Obermayer-Pietsch B; Grabmeier-Pfistershammer K; Trauner M; Peck-Radosavljevic M; Reiberger T, 2015. Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3.  Liver Int 35(3):876-85

Schwabl P; Bota S; Salzl P; Mandorfer M; Payer BA; Ferlitsch A; Stift J; Wrba F; Trauner M; Peck-Radosavljevic M; Reiberger T, 2015. New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertension.  Liver Int 35(2):381-90

Mandorfer M; Steiner S; Schwabl P; Payer BA; Aichelburg MC; Lang G; Grabmeier-Pfistershammer K; Trauner M; Peck-Radosavljevic M; Reiberger T, 2015. Response-guided boceprevir-based triple therapy in HIV/HCV-coinfected patients: the HIVCOBOC-RGT study.  J Infect Dis 211(5):729-35

Reiberger T, 2015. Chronic hepatitis C: treat everyone now or stratify by disease?  Minerva Gastroenterol Dietol 61(1):11-9

Ferlitsch A; Bota S; Paternostro R; Reiberger T; Mandorfer M; Heinisch B; Salzl P; Schwarzer R; Sieghart W; Peck-Radosavljevic M; Ferlitsch M, 2015. Evaluation of a new balloon occlusion catheter specifically designed for measurement of hepatic venous pressure gradient.  Liver Int 35(9):2115-20

Schwabl P; Bucsics T; Soucek K; Mandorfer M; Bota S; Blacky A; Hirschl AM; Ferlitsch A; Trauner M; Peck-Radosavljevic M; Reiberger T, 2015. Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascites.  Liver Int 35(9):2121-8

Jansen C; Reiberger T; Huang J; Eischeid H; Schierwagen R; Mandorfer M; Anadol E; Schwabl P; Schwarze-Zander C; Warnecke-Eberz U; Strassburg CP; Rockstroh JK; Peck-Radosavljevic M; Odenthal M; Trebicka J, 2015. Circulating miRNA-122 levels are associated with hepatic necroinflammation and portal hypertension in HIV/HCV coinfection.  PLoS One 10(2):e0116768

Sulzgruber P; Koller L; Reiberger T; El-Hamid F; Forster S; Rothgerber DJ; Goliasch G; Wojta J; Niessner A, 2015. Butyrylcholinesterase predicts cardiac mortality in young patients with acute coronary syndrome.  PLoS One 10(5):e0123948

Bucsics T; Mandorfer M; Schwabl P; Bota S; Sieghart W; Ferlitsch A; Trauner M; Peck-Radosavljevic M; Reiberger T, 2015. Impact of acute kidney injury on prognosis of patients with liver cirrhosis and ascites: A retrospective cohort study.  J Gastroenterol Hepatol 30(11):1657-65

Bota S; Paternostro R; Etschmaier A; Schwarzer R; Salzl P; Mandorfer M; Kienbacher C; Ferlitsch M; Reiberger T; Trauner M; Peck-Radosavljevic M; Ferlitsch A, 2015. Performance of 2-D shear wave elastography in liver fibrosis assessment compared with serologic tests and transient elastography in clinical routine.  Ultrasound Med Biol 41(9):2340-9

Pinter M; Ulbrich G; Sieghart W; Kölblinger C; Reiberger T; Li S; Ferlitsch A; Müller C; Lammer J; Peck-Radosavljevic M, 2015. Hepatocellular Carcinoma: A Phase II Randomized Controlled Double-Blind Trial of Transarterial Chemoembolization in Combination with Biweekly Intravenous Administration of Bevacizumab or a Placebo.  Radiology 277(3):903-12

Mandorfer M; Kozbial K; Freissmuth C; Schwabl P; Stättermayer AF; Reiberger T; Beinhardt S; Schwarzer R; Trauner M; Ferlitsch A; Hofer H; Peck-Radosavljevic M; Ferenci P, 2015. Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses.  Aliment Pharmacol Ther 42(6):707-18

Reiberger T; Chen Y; Ramjiawan RR; Hato T; Fan C; Samuel R; Roberge S; Huang P; Lauwers GY; Zhu AX; Bardeesy N; Jain RK; Duda DG, 2015. An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis.  Nat Protoc 10(8):1264-74

Aichelburg MC; Weseslindtner L; Mandorfer M; Strassl R; Rieger A; Reiberger T; Puchhammer-Stöckl E; Grabmeier-Pfistershammer K, 2015. Association of CMV-Specific T Cell-Mediated Immunity with CMV DNAemia and Development of CMV Disease in HIV-1-Infected Individuals.  PLoS One 10(8):e0137096

Scheiner B; Mandorfer M; Schwabl P; Payer BA; Bucsics T; Bota S; Aichelburg MC; Grabmeier-Pfistershammer K; Stättermayer A; Ferenci P; Trauner M; Peck-Radosavljevic M; Reiberger T, 2015. The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection.  PLoS One 10(11):e0143429

Mandorfer M; Payer BA; Scheiner B; Breitenecker F; Aichelburg MC; Grabmeier-Pfistershammer K; Rieger A; Trauner M; Peck-Radosavljevic M; Reiberger T, 2014. Health-related quality of life and severity of fatigue in HIV/HCV co-infected patients before, during, and after antiviral therapy with pegylated interferon plus ribavirin.  Liver Int 34(1):69-77

Strassl R; Reiberger T; Honsig C; Payer BA; Mandorfer M; Grabmeier-Pfistershammer K; Rieger A; Kundi M; Grundtner P; Peck-Radosavljevic M; Popow-Kraupp T, 2014. Viral determinants predicting hepatitis B surface antigen (HBsAg) seroclearance in HIV-/HBV-coinfected patients.  J Viral Hepat 21(7):508-16

Mandorfer M; Reiberger T; Payer BA; Breitenecker F; Aichelburg MC; Obermayer-Pietsch B; Rieger A; Puoti M; Zangerle R; Trauner M; Peck-Radosavljevic M, 2014. Revisiting predictors of virologic response to PEGIFN + RBV therapy in HIV-/HCV-coinfected patients: the role of metabolic factors and elevated GGT levels.  J Viral Hepat 21(1):33-41

Mandorfer M; Bota S; Schwabl P; Bucsics T; Pfisterer N; Kruzik M; Hagmann M; Blacky A; Ferlitsch A; Sieghart W; Trauner M; Peck-Radosavljevic M; Reiberger T, 2014. Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis.  Gastroenterology 146(7):1680-90.e1

Mandorfer M; Neukam K; Rivero A; Puoti M; Boesecke C; Baumgarten A; Grzeszczuk A; Zangerle R; Ernst D; Rockstroh JK; Trauner M; Pineda JA; Peck-Radosavljevic M; Reiberger T, 2014. Strategies for assignment of HIV-HCV genotype-1-coinfected patients to either dual-therapy or direct-acting antiviral agent-based triple-therapy.  Antivir Ther 19(4):407-14

Schwabl P; Payer BA; Grahovac J; Klein S; Horvatits T; Mitterhauser M; Stift J; Boucher Y; Trebicka J; Trauner M; Angermayr B; Fuhrmann V; Reiberger T; Peck-Radosavljevic M, 2014. Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats.  J Hepatol 60(6):1135-42

Jansen C; Leeming DJ; Mandorfer M; Byrjalsen I; Schierwagen R; Schwabl P; Karsdal MA; Anadol E; Strassburg CP; Rockstroh J; Peck-Radosavljevic M; Møller S; Bendtsen F; Krag A; Reiberger T; Trebicka J, 2014. PRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertension.  PLoS One 9(9):e108544

Real LM; Neukam K; Herrero R; Guardiola JM; Reiberger T; Rivero-Juarez A; Salazar J; Mandorfer M; Merino D; Soriano V; Rivero A; Macías J; Pineda JA; Caruz A, 2014. IFNL4 ss469415590 variant shows similar performance to rs12979860 as predictor of response to treatment against Hepatitis C Virus genotype 1 or 4 in Caucasians.  PLoS One 9(4):e95515

Mandorfer M; Payer BA; Niederecker A; Lang G; Aichelburg MC; Strassl R; Boesecke C; Rieger A; Trauner M; Peck-Radosavljevic M; Reiberger T, 2014. Therapeutic potential of and treatment with boceprevir/telaprevir-based triple-therapy in HIV/chronic hepatitis C co-infected patients in a real-world setting.  AIDS Patient Care STDS 28(5):221-7

Aichelburg MC; Mandorfer M; Tittes J; Breitenecker F; Reiberger T; Rieger A; Kohrgruber N, 2014. The association of smoking with IGRA and TST results in HIV-1-infected subjects.  Int J Tuberc Lung Dis 18(6):709-16

Mandorfer M; Peck-Radosavljevic M; Reiberger T, 2014. Reply: To PMID 24631577.  Gastroenterology 147(4):942

Reiberger T, 2014. Acute hepatitis C virus infection in HIV-infected men who have sex with men: should we change our screening practice?  Clin Infect Dis 59(12):1694-5

Mandorfer M; Bota S; Schwabl P; Bucsics T; Pfisterer N; Summereder C; Hagmann M; Blacky A; Ferlitsch A; Sieghart W; Trauner M; Peck-Radosavljevic M; Reiberger T, 2014. Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites.  PLoS One 9(11):e110503

Mandorfer M; Neukam K; Reiberger T; Payer BA; Rivero A; Puoti M; Boesecke C; Baumgarten A; Grzeszczuk A; Zangerle R; Meyer-Olson D; Rockstroh JK; Trauner M; Pineda JA; Peck-Radosavljevic M, 2013. The impact of interleukin 28B rs12979860 single nucleotide polymorphism and liver fibrosis stage on response-guided therapy in HIV/HCV-coinfected patients.  AIDS 27(17):2707-14

Reiberger T; Payer BA; Schwabl P; Hayden H; Horvatits T; Jäger B; Hummel T; Mitterhauser M; Trauner M; Fuhrmann V; Angermayr B; Peck-Radosavljevic M, 2013. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.  Liver Int 33(4):561-8

Reiberger T; Ferlitsch A; Payer BA; Mandorfer M; Heinisch BB; Hayden H; Lammert F; Trauner M; Peck-Radosavljevic M; Vogelsang H, 2013. Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis.  J Hepatol 58(5):911-21

Reiberger T; Ulbrich G; Ferlitsch A; Payer BA; Schwabl P; Pinter M; Heinisch BB; Trauner M; Kramer L; Peck-Radosavljevic M, 2013. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.  Gut 62(11):1634-41

Mandorfer M; Reiberger T; Payer BA; Ferlitsch A; Breitenecker F; Aichelburg MC; Obermayer-Pietsch B; Rieger A; Trauner M; Peck-Radosavljevic M, 2013. Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients.  AIDS 27(2):227-32

Payer BA; Reiberger T; Aberle J; Ferenci P; Holzmann H; Rieger A; Peck-Radosavljevic M, 2012. IL28B and interferon-gamma inducible protein 10 for prediction of rapid virologic response and sustained virologic response in HIV-HCV-coinfected patients.  Eur J Clin Invest 42(6):599-606

Reiberger T; Ferlitsch A; Payer BA; Pinter M; Homoncik M; Peck-Radosavljevic M, 2012. Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis.  J Gastroenterol 47(5):561-8

Payer BA; Reiberger T; Breitenecker F; Aichelburg MC; Schuster C; Heil PM; Scherzer TM; Ferenci P; Rieger A; Peck-Radosavljevic M, 2012. The risk of infections in HIV-HCV coinfected patients during antiviral therapy with pegIFN+RBV.  J Infect 65(2):142-9

Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A, 2012. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.  Hepatology 56(4):1439-47

Aichelburg MC; Tittes J; Breitenecker F; Reiberger T; Kohrgruber N; Rieger A, 2012. Prognostic value of indeterminate IFN-γ release assay results in HIV-1 infection.  J Clin Microbiol 50(8):2767-9

Reiberger T; Payer BA; Ferlitsch A; Sieghart W; Breitenecker F; Aichelburg MC; Schmied B; Rieger A; Trauner M; Peck-Radosavljevic M, 2012. A prospective evaluation of pulmonary, systemic and hepatic haemodynamics in HIV-HCV-coinfected patients before and after antiviral therapy with pegylated interferon and ribavirin.  Antivir Ther 17(7):1327-34

Kosi L; Reiberger T; Payer BA; Grabmeier-Pfistershammer K; Strassl R; Rieger A; Peck-Radosavljevic M, 2012. Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients.  J Viral Hepat 19(11):801-10

Reiberger T; Obermeier M; Payer BA; Baumgarten A; Weitner L; Moll A; Christensen S; Köppe S; Kundi M; Rieger A; Peck-Radosavljevic M, 2011. Considerable under-treatment of chronic HCV infection in HIV patients despite acceptable sustained virological response rates in a real-life setting.  Antivir Ther 16(6):815-24

Reiberger T; Payer BA; Kosi L; Heil PM; Rieger A; Peck-Radosavljevic M, 2011. Concomitant highly active antiretroviral therapy leads to smaller decline and faster recovery of CD4+ cell counts during and after pegylated interferon plus ribavirin therapy in HIV-hepatitis C virus coinfected patients.  J Infect Dis 203(12):1802-6

Reiberger T; Rutter K; Ferlitsch A; Payer BA; Hofer H; Beinhardt S; Kundi M; Ferenci P; Gangl A; Trauner M; Peck-Radosavljevic M, 2011. Portal pressure predicts outcome and safety of antiviral therapy in cirrhotic patients with hepatitis C virus infection.  Clin Gastroenterol Hepatol 9(7):602-8.e1

Payer BA; Reiberger T; Rutter K; Beinhardt S; Staettermayer AF; Peck-Radosavljevic M; Ferenci P, 2010. Successful HCV eradication and inhibition of HIV replication by intravenous silibinin in an HIV-HCV coinfected patient.  J Clin Virol 49(2):131-3

Reiberger T; Kosi L; Maresch J; Breitenecker F; Payer BA; Wrba F; Rieger A; Gangl A; Peck-Radosavljevic M, 2010. Mitochondrial toxicity is associated with virological response in patients with HIV and hepatitis C virus coinfection treated with ribavirin and highly active antiretroviral therapy.  J Infect Dis 202(1):156-60

Reiberger T; Ferlitsch A; Sieghart W; Kreil A; Breitenecker F; Rieger A; Schmied B; Gangl A; Peck-Radosavljevic M, 2010. HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension.  J Viral Hepat 17(6):400-9

Reiberger T; Angermayr B; Schwabl P; Rohr-Udilova N; Mitterhauser M; Gangl A; Peck-Radosavljevic M, 2009. Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats.  J Hepatol 51(5):865-73

Sieghart W; Fellner S; Reiberger T; Ulbrich G; Ferlitsch A; Wacheck V; Peck-Radosavljevic M, 2009. Differential role of circulating endothelial progenitor cells in cirrhotic patients with or without hepatocellular carcinoma.  Dig Liver Dis 41(12):902-6

Angermayr B; Luca A; König F; Bertolini G; Ploner M; Gridelli B; Ulbrich G; Reiberger T; Bosch J; Peck-Radosavljevic M, 2009. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.  Eur J Clin Invest 39(1):65-71

Reiberger T; Aberle JH; Kundi M; Kohrgruber N; Rieger A; Gangl A; Holzmann H; Peck-Radosavljevic M, 2008. IP-10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or non-response in HIV-HCV coinfection.  Antivir Ther 13(8):969-76

Publication list retrieved from NCBI using ImpactPubs

.